Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ulrike Schick

Showing results (41-50 of 141) with videos related to

Pageof 15
Sort By:
Frontiers in Oncology|September 12, 2019
MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate CancerVincent Bourbonne, Martin Vallières, François Lucia, et al.
Clinical and Translational Radiation Oncology|May 22, 2020
Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapyFrançois Lucia, Vincent Bourbonne, Dorothy Gujral, et al.
Cancers|February 11, 2023
Re-Irradiation by Stereotactic Radiotherapy of Brain Metastases in the Case of Local RecurrenceRuben Touati, Vincent Bourbonne, Gurvan Dissaux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2024
PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative RadiotherapyVincent Bourbonne, Moncef Morjani, Olivier Pradier, et al.
Journal of Cancer Research and Clinical Oncology|June 11, 2021
The prognostic significance of PD-L1 expression on tumor and immune cells in Merkel cell carcinomaMorgan Guénolé, Paolo Bénigni, Vincent Bourbonne, et al.
Cancers|April 3, 2021
Dosimetric Validation of a GAN-Based Pseudo-CT Generation for MRI-Only Stereotactic Brain RadiotherapyVincent Bourbonne, Vincent Jaouen, Clément Hognon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose DistributionsSophie Otter, Ulrike Schick, Sarah Gulliford, et al.
Human Pathology|December 7, 2017
Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cellsGlen Le Flahec, Bogdan Badic, Briac Guibourg, et al.
Medicine|September 3, 2020
Diagnostic performance of a whole-body dynamic 68GA-DOTATOC PET/CT acquisition to differentiate physiological uptake of pancreatic uncinate process from pancreatic neuroendocrine tumorPhilippe Thuillier, David Bourhis, Nicolas Karakatsanis, et al.
BMJ Supportive & Palliative Care|September 19, 2019
Radiotherapy mucositis in head and neck cancer: prevention by low-energy surface laserVincent Bourbonne, Joelle Otz, René-Jean Bensadoun, et al.
Pageof 15

Showing results (41-50 of 141) with videos related to

Sort By:
Pageof 15
Frontiers in Oncology|September 12, 2019
MRI-Derived Radiomics to Guide Post-operative Management for High-Risk Prostate CancerVincent Bourbonne, Martin Vallières, François Lucia, et al.
Clinical and Translational Radiation Oncology|May 22, 2020
Impact of suboptimal dosimetric coverage of pretherapeutic 18F-FDG PET/CT hotspots on outcome in patients with locally advanced cervical cancer treated with chemoradiotherapy followed by brachytherapyFrançois Lucia, Vincent Bourbonne, Dorothy Gujral, et al.
Cancers|February 11, 2023
Re-Irradiation by Stereotactic Radiotherapy of Brain Metastases in the Case of Local RecurrenceRuben Touati, Vincent Bourbonne, Gurvan Dissaux, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 15, 2024
PET/CT-Based Radiogenomics Supports KEAP1/NFE2L2 Pathway Targeting for Non-Small Cell Lung Cancer Treated with Curative RadiotherapyVincent Bourbonne, Moncef Morjani, Olivier Pradier, et al.
Journal of Cancer Research and Clinical Oncology|June 11, 2021
The prognostic significance of PD-L1 expression on tumor and immune cells in Merkel cell carcinomaMorgan Guénolé, Paolo Bénigni, Vincent Bourbonne, et al.
Cancers|April 3, 2021
Dosimetric Validation of a GAN-Based Pseudo-CT Generation for MRI-Only Stereotactic Brain RadiotherapyVincent Bourbonne, Vincent Jaouen, Clément Hognon, et al.
International Journal of Radiation Oncology, Biology, Physics|October 14, 2015
Evaluation of the Risk of Grade 3 Oral and Pharyngeal Dysphagia Using Atlas-Based Method and Multivariate Analyses of Individual Patient Dose DistributionsSophie Otter, Ulrike Schick, Sarah Gulliford, et al.
Human Pathology|December 7, 2017
Mismatch repair-deficient colorectal cancer: a model of immunogenic and immune cell-rich tumor despite nonsignificant programmed cell death ligand-1 expression in tumor cellsGlen Le Flahec, Bogdan Badic, Briac Guibourg, et al.
Medicine|September 3, 2020
Diagnostic performance of a whole-body dynamic 68GA-DOTATOC PET/CT acquisition to differentiate physiological uptake of pancreatic uncinate process from pancreatic neuroendocrine tumorPhilippe Thuillier, David Bourhis, Nicolas Karakatsanis, et al.
BMJ Supportive & Palliative Care|September 19, 2019
Radiotherapy mucositis in head and neck cancer: prevention by low-energy surface laserVincent Bourbonne, Joelle Otz, René-Jean Bensadoun, et al.
Pageof 15